SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001047469-21-000931
Filing Date
2021-04-13
Accepted
2021-04-12 17:48:08
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFM14A a2243190zdefm14a.htm DEFM14A 2993370
2 G967154.JPG g967154.jpg GRAPHIC 10704
3 G520691.JPG g520691.jpg GRAPHIC 8819
4 G814640.JPG g814640.jpg GRAPHIC 3392
5 G456188.JPG g456188.jpg GRAPHIC 3107
6 G167339.JPG g167339.jpg GRAPHIC 9771
7 G150974.JPG g150974.jpg GRAPHIC 4016
8 G158582.JPG g158582.jpg GRAPHIC 164712
9 G195627.JPG g195627.jpg GRAPHIC 164665
  Complete submission text file 0001047469-21-000931.txt   3504053
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-27756 | Film No.: 21821547
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences